Surrozen (SRZN) EPS (Weighted Average and Diluted) Growth (1y) (2022 - 2026)
Surrozen (SRZN) EPS (Weighted Average and Diluted) Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
251.11% |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
-13.31% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
102.51% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-79.34% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
-103.05% |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
61.45% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Surrozen |
239,016.67 |
-106.67 Mn |
- |
-56.80% |
| Date | Value |
|---|
| Mar 31, 2026 |
-56.80% |
| Dec 31, 2025 |
-162.42% |
| Sep 30, 2025 |
-1,800.00% |
| Jun 30, 2025 |
131.91% |
| Mar 31, 2025 |
-75.24% |
| Dec 31, 2024 |
-108.24% |
| Sep 30, 2024 |
91.44% |
| Jun 30, 2024 |
-70.73% |
| Mar 31, 2024 |
40.78% |
| Dec 31, 2023 |
99.40% |
| Sep 30, 2023 |
-1,252.63% |
| Jun 30, 2023 |
-1,070.00% |
| Mar 31, 2023 |
-3,013.04% |
| Dec 31, 2022 |
-20.94% |
| Sep 30, 2022 |
25.49% |
| Jun 30, 2022 |
42.03% |
